Metronidazol shortage — NL supply status & alternatives

Metronidazol

—

🇦🇺 AUST R 384574 · Interpharma Pty Ltd

In supply · Australia

In supply · 🇦🇺 Australia · short in🇳🇱 NL🇳🇴 NO

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Marketing-authorisation holders
Active ingredient (INN)	Metronidazol
Therapeutic category	Auto-created by CBG-MEB (Netherlands) scraper
Controlled substance	No

Registrations on file	18

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Other markets

🇪🇸 ES

€5.37

Retail price

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 3 resolved events

◷

~1 month

Historical pattern from resolved shortage records — not a prediction of this event.

Shortage status by regulator official notices

🇳🇱

Netherlands

CBG-MEB · 1d ago

Medium

🇳🇴

Norway

NOMA · 4d ago

Resolved

Verified timeline regulator events

🇳🇴 15 July 2026

medium reported

🇳🇱 26 June 2026

medium reported

🇳🇴 5 June 2026

medium reported

🇳🇱 4 June 2026

medium reported

🇳🇱 18 May 2026

medium reported

🇳🇴 30 Apr 2026

Shortage resolved

Sources official regulators

🇳🇱

CBG-MEB

verified 1d ago

verify ↗

🇳🇴

NOMA

verified 4d ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders18 registrations · 12 MA holders

Product	Strength	Form	Market	MA holder	Status
METRONIDAZOLE NORIDEM, metronidazole	500mg	—	🇦🇺 AU	Interpharma Pty Ltd	Active
METRONIDAZOLE MEDICIANZ metronidazole	500 mg	—	🇦🇺 AU	Medicianz Healthcare Pty Ltd	Active
METRONIDAZOLE MEDSURGE metronidazole	500 mg	—	🇦🇺 AU	Medicianz Healthcare Pty Ltd	Active
Metronidazole	500MG	infusion	🇬🇧 GB	BAXTER HEALTHCARE LIMITED	Active
Metronidazole Tablets Bp	200MG	tablet	🇬🇧 GB	ACCORD-UK LIMITED	Active
Metronidazole Tablets Bp	400MG	tablet	🇬🇧 GB	ACCORD-UK LIMITED	Active
Metronidazole	200MG	suspension	🇬🇧 GB	ROSEMONT PHARMACEUTICALS LIMITED	Active
Metrolyl Suppositories	500MG	metrolyl	🇬🇧 GB	SANDOZ LIMITED	Active
Metrolyl Suppositories	1G	metrolyl	🇬🇧 GB	SANDOZ LIMITED	Active
Metrolyl	200MG	tablet	🇬🇧 GB	SANDOZ LIMITED	Active
Metrolyl	400MG	tablet	🇬🇧 GB	SANDOZ LIMITED	Active
Metronidazole	400MG	tablet	🇬🇧 GB	PHARMVIT LIMITED	Active
Metronidazole 0.75% W/W Gel	0.75%	gel	🇬🇧 GB	MERCURY PHARMACEUTICALS LIMITED	Active
Metronidazole	500 MG	solution	🇬🇧 GB	MERCURY PHARMACEUTICALS LIMITED	Active
Metronidazole	5 MG	solution	🇬🇧 GB	HIKMA FARMACEUTICA (PORTUGAL) SA	Active

+3 more registrations on file

Mederti Drug Report

Generated 3 July 2026 · Australia market · 2 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.